Vela Diagnostics Signs Collaboration Agreements With Eppendorf

Informations

• Publié par: vela-diagnostics
• Nombre de lectures: 17
• Langue: English

Extrait

Vela Diagnostics Signs Collaboration

Agreements With Eppendorf

PR Newswire

SINGAPORE, July 12, 2012

SINGAPORE

,

July 12, 2012

/PRNewswire/ --

Vela Diagnostics and Eppendorf have agreed to jointly develop an IVD RNA/DNA

extraction platform - called "Sentosa SX". The new system is based on

Eppendorf's world class pipetting and liquid handling technology and Vela's

broad IVD and workflow know-how.

Following on the deal, VelaDx and Eppendorf scientists and engineers have

customized Eppendorf's epMotion system with an efficient diagnostic workflow

and features exclusive to VelaDx. The enhancements focused on gaining

workflow efficiency and IT connectivity, while minimizing potential errors and

cross contamination arising from manual set up processes. The "Sentosa SX"

platform is uniquely able to set up and simultaneously carry out four different

tests per run.

Commenting on the joint development, VelaDx CEO Michael Tillmann said, "Our

collaboration merges an already robust epMotion with revolutionary system

enhancements. The new customized hardware and software on the "Sentosa

SX" system will enhance workflow efficiency in laboratories and improve

sample traceability. It will be easier for lab staff and they can maximize their

time in other value adding tasks."

The new "Sentosa SX" extraction platform connects with VelaDx's PCR

detection. The Company's "Sentosa" workflow systems and "Sentosa" test kits

will be launched in selected Asian and European markets in Q3 2012. The

Group is also making submissions for regulatory approval in the US.

About Vela Diagnostics

VelaDx provides a broad menu of molecular diagnostic tests, consolidated on

its automated "Sentosa" workflow system. The Group was incorporated by an

industry experienced management team in 2011 with the vision of providing

in-

vitro

diagnostic solutions for customers to achieve improved laboratory

management. VelaDx is a privately owned Group of Companies headquartered

in

Singapore

. The Asia Pacific, European and North American commercial

operations of the Group are based in

Singapore

,

Hamburg

and

New Jersey

,

respectively. VelaDx also operates R&D sites in

Singapore

and

New Jersey

in

addition to a Global Manufacturing facility in

Singapore

. For more information,

please visit us at http://www.veladx.com

Contact:

Peter Matthiesen

Vela Diagnostics Germany GmbH

e-Mail: [e-mail],

Telefon: [phone]